greeksoup/ stock research

Healthpeak Properties (DOC) FY2024 results: revenue $2.7 billion, up 23.8% on the year

Healthpeak Properties, Inc. (DOC) reported revenue of $2.7 billion for fiscal 2024, the year ended 31 December 2024, up 23.8% on the year before. Net income was $243 million, down 20.5%, and diluted earnings per share $0.36. The figures are the company's own, from the 10-K it filed with the SEC on 4 February 2025.

Revenue
$2.7 billion
+23.8% on the year
FY2017FY2024
Operating margin
1.3%
10.2% a year earlier
FY2017FY2024
Net income
$243 million
-20.5% on the year
FY2017FY2024
Diluted EPS
$0.36
-35.7% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue2,7002,1812,061+23.8%
Cost of revenue1,075902863+19.2%
Gross profit1,6261,2791,198+27.1%
Gross margin60.2%58.6%58.1%
Operating income35.1222172-84.2%
Operating margin1.3%10.2%8.3%
Interest expense280200173+40.0%
Pre-tax income273315507-13.3%
Income tax4.3-9.6-4.4
Effective tax rate1.6%-3.1%-0.9%
Net income243306500-20.5%
Net margin9.0%14.0%24.3%
Diluted EPS$0.36$0.56$0.92-35.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow1,070956900+11.9%
Capital expenditure737775962-4.9%
Free cash flow334182-61.7+83.7%
Free cash flow margin12.4%8.3%-3.0%
Cash from investing-114-577-876
Cash from financing-941-337-117
Depreciation and amortisation1,057750711+41.0%
Share-based compensation15.514.526.5+7.3%
Buybacks1916.567.8+2,822.9%
Dividends paid795657648+21.0%
Dividend per share$1.20$1.20$1.200.0%
Diluted shares, weighted676m547m539m+23.6%
Shares outstanding at period end699m547m547m+27.8%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity8,4016,3506,655+32.3%
Non-controlling interest654526528+24.4%
Redeemable equity2.648.8106-94.7%
Debt8,7166,8766,498+26.8%
Other liabilities2,1651,8981,985+14.1%
Total liabilities and equity19,93815,69915,771+27.0%
Goodwill68.518.018.0+280.7%
Intangible assets817314418+160.1%
Loans656218375+200.3%
Cash and equivalents12011872.0+1.9%
Other assets18,27715,03114,888+21.6%
Total assets19,93815,69915,771+27.0%

10-K for the year ended 31 December 2024, filed 4 February 2025: the filing.